Rasagiline mesylate and Peripheral swelling - a phase IV clinical study of FDA data
We study 638 people who have side effects when taking Rasagiline mesylate. Peripheral swelling is found, especially among people who are male, 60+ old, also take Nuplazid and have Hallucinations.
The phase IV clinical study analyzes which people take Rasagiline mesylate and have Peripheral swelling. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
638 people reported to have side effects when taking Rasagiline mesylate.
Among them, 13 people (2.04%) have Peripheral swelling.
What is Rasagiline mesylate?
Rasagiline mesylate has active ingredients of rasagiline mesylate. Currently, eHealthMe is studying from 661 Rasagiline mesylate users.
What is Peripheral swelling?
Peripheral swelling is found to be associated with 2,602 drugs and 1,662 conditions by eHealthMe. Currently, we are studying 156,380 people who have Peripheral swelling.
Number of Rasagiline mesylate and Peripheral swelling reports submitted per year:
Gender of people who have Peripheral swelling when taking Rasagiline mesylate*:
Age of people who have Peripheral swelling when taking Rasagiline mesylate *:
Common drugs people take besides Rasagiline mesylate *:
Common side effects people have besides Peripheral swelling *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Rasagiline mesylate and have Peripheral swelling?Check whether Peripheral swelling is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Hipoglisemi RB, "Rasagiline-Induced Hypoglycemia", , 2016 Jan .
How severe was Peripheral swelling and when was it recovered:
Expand to all the drugs that have ingredients of rasagiline mesylate:
Alternative drugs to, pros and cons of Rasagiline mesylate:
- Rasagiline mesylate (661 reports)
Browse all side effects of Rasagiline mesylate:a b c d e f g h i j k l m n o p q r s t u v w x y z
Peripheral swelling treatments and more:
- Peripheral swelling (156,380 reports)
Common drugs associated with Peripheral swelling:
- Humira: 16,512 reports
- Enbrel: 16,196 reports
- Methotrexate: 16,044 reports
- Prednisone: 14,540 reports
- Xeljanz: 9,922 reports
- Actemra: 8,213 reports
- Arava: 7,579 reports
- Orencia: 7,169 reports
- Aspirin: 7,146 reports
- Sulfasalazine: 7,137 reports
All the drugs that are associated with Peripheral swelling:
- Peripheral swelling (2,602 drugs)
Common conditions associated with Peripheral swelling:
- Rheumatoid arthritis: 25,579 reports
- High blood pressure: 6,543 reports
- Multiple myeloma: 5,904 reports
- Primary pulmonary hypertension: 5,883 reports
- Pain: 4,820 reports
- Multiple sclerosis: 4,060 reports
- Psoriasis: 3,978 reports
All the conditions that are associated with Peripheral swelling:
- Peripheral swelling (1,662 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on rasagiline mesylate (the active ingredients of Rasagiline mesylate) and Rasagiline mesylate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Tigan and Neck Pain - 8 seconds ago
- Zometa and Burns Second Degree - 10 seconds ago
- Klor-Con M10 and Fexofenadine Hydrochloride drug interaction - 12 seconds ago
- Meropenem and Eosinophilia - 23 seconds ago
- Invega Sustenna and Heart Palpitations - 23 seconds ago
- Claritin Reditabs and Keppra drug interaction - 29 seconds ago
- Polysporin and Metformin Hydrochloride drug interaction - 31 seconds ago
- Ogen and Emotional Distress - 34 seconds ago
- Hydramine and Olmesartan Medoxomil drug interaction - 35 seconds ago
- Folic Acid and Hypersplenism - 45 seconds ago